NEW YORK (Reuters Health) – A new analysis of pooled data on omalizumab should help allay concerns that omalizumab (Xolair; Genentech, Novartis) may increase the risk for cancer.…
NEW YORK (Reuters Health) – Iron-deficiency anemia can lead to high glycosylated hemoglobin (HbA1c) concentrations that do not reflect glycemic parameters, an Indian study has shown. “The use…
NEW YORK (Reuters Health) – In patients with type 2 diabetes, glycemic control is better and weight loss is sustained up to 84 weeks with exenatide once weekly…
NEW YORK (Reuters Health) – Malnourished adults aged 60 and older who started an energy- and protein-enriched nutritional plan plus calcium and vitamin D supplements following hospital discharge…
NEW YORK (Reuters Health) – Giving the probiotic Lactobacillus reuteri DSM 17938 to hospitalized children is unlikely to protect them from nosocomial diarrhea, including rotavirus infection, according to…
NEW YORK (Reuters Health) – Increases in fasting blood sugar levels are often seen in patients starting niacin, sometimes to a level that suggests new onset of type…
NEW YORK (Reuters Health) – Adding trimetazidine to the treatment of chronic heart failure improves cardiac function and slows left ventricular remodeling, according to the results of a…
NEW YORK (Reuters Health) – Lung cancer patients undergoing chemotherapy can be treated safely with erythropoiesis-stimulating agents (ESAs), according to findings published in the 24 January online issue…
NEW YORK (Reuters Health) – A review suggests that wound-edge protection devices (WEPDs) may be useful in surgical patients, UK researchers report in a January 26th on-line paper…
NEW YORK (Reuters Health) – Men 60 years old and younger have excellent quality-of-life outcomes after proton therapy for prostate cancer, according to findings published in the January…
